価格表

在庫・価格 : 2024年05月04日 13時07分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ErbB3, Total, Human, DuoSet IC Kit (2 plates)
データシート※最新のデータシートでない場合があります
DYC234-2 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥83,000
(未発注)
追加

在庫・価格 : 2024年05月04日 13時07分 現在

ErbB3, Total, Human, DuoSet IC Kit (2 plates)

  • 商品コード:DYC234-2
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥83,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sarup J et al. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts. Mol. Cancer Ther. 2008 Oct;7(10):3223-36
Sarup J et al
2008/01/01
Sample Type: Cell Lysates PubMed
2 Desbois-Mouthon C et al. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epiderma
Desbois-Mouthon C et al
2009/01/01
Sample Type: Cell Lysates PubMed
3 Hickinson DM et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci 2009 Jun;2(3):183-92
Hickinson DM et al
2009/01/01
Sample Type: Cell Lysates PubMed
4 Yamashita-Kashima Y et al. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. Clin. Cancer Res. 2011 Aug;17(15):5060-70
Yamashita-Kashima Y et al
2011/01/01
Sample Type: Homogenized Tissue PubMed
  • No.: 1
  • 文献情報:
    Sarup J et al. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts. Mol. Cancer Ther. 2008 Oct;7(10):3223-36
    Sarup J et al
    2008/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Desbois-Mouthon C et al. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epiderma
    Desbois-Mouthon C et al
    2009/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hickinson DM et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci 2009 Jun;2(3):183-92
    Hickinson DM et al
    2009/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Yamashita-Kashima Y et al. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. Clin. Cancer Res. 2011 Aug;17(15):5060-70
    Yamashita-Kashima Y et al
    2011/01/01
  • 備考:
    Sample Type: Homogenized Tissue
  • 参照:
    PubMed